103 related articles for article (PubMed ID: 27798495)
1. Novel Agents for Antimicrobial Solutions.
Mohammadzadeh R
Eye Contact Lens; 2016 Nov; 42(6):401-402. PubMed ID: 27798495
[No Abstract] [Full Text] [Related]
2. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
3. The role of iontophoresis in ocular drug delivery.
Sarraf D; Lee DA
J Ocul Pharmacol; 1994; 10(1):69-81. PubMed ID: 8207346
[TBL] [Abstract][Full Text] [Related]
4. Integrating iquix, vigamox, and zymar in the management of ocular infectious disease.
McLeod SD
Int Ophthalmol Clin; 2006; 46(4):41-5. PubMed ID: 17060790
[No Abstract] [Full Text] [Related]
5. [Anti-infectives in eye injuries].
Behrens-Baumann W
Klin Monbl Augenheilkd; 2004 Aug; 221(8):674-6. PubMed ID: 15343451
[TBL] [Abstract][Full Text] [Related]
6. Antisepsis versus antimicrobial chemotherapy and indications for eye antisepsis.
Kramer A; Behrens-Baumann W
Dev Ophthalmol; 2002; 33():14-27. PubMed ID: 12236107
[No Abstract] [Full Text] [Related]
7. Challenges in ocular infectious diseases and the evolution of anti-infective therapy.
Olson RJ
Surv Ophthalmol; 2004 Mar; 49 Suppl 2():S53-4. PubMed ID: 15028479
[No Abstract] [Full Text] [Related]
8. [Pharmacotherapy of eye infection].
Maĭchuk IuF
Antibiot Khimioter; 1999; 44(1):26-30. PubMed ID: 10095922
[No Abstract] [Full Text] [Related]
9. Magnetic nanoparticles for antimicrobial drug delivery.
Azhar SL; Lotfipour F
Pharmazie; 2012 Oct; 67(10):817-21. PubMed ID: 23136713
[TBL] [Abstract][Full Text] [Related]
10. Identification of anti-infective targets through comparative proteomics.
Burchmore R
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
[No Abstract] [Full Text] [Related]
11. Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.
Velpandian T
Expert Opin Drug Deliv; 2009 Mar; 6(3):255-70. PubMed ID: 19327043
[TBL] [Abstract][Full Text] [Related]
12. Contribution of complement to defensin action in eye.
Prohászka Z; Füst G
Lancet; 1998 Oct; 352(9134):1152. PubMed ID: 9798625
[No Abstract] [Full Text] [Related]
13. [Physical and chemical stability of fortified ophtalmic ready-to-use solutions: review of literature].
Sourdeau P; Evrard JM; Remy G; Hecq JD
Ann Pharm Fr; 2012 Mar; 70(2):104-12. PubMed ID: 22500962
[TBL] [Abstract][Full Text] [Related]
14. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
[TBL] [Abstract][Full Text] [Related]
15. In situ formation of antimicrobial silver nanoparticles and the impregnation of hydrophobic polycaprolactone matrix for antimicrobial medical device applications.
Tran PA; Hocking DM; O'Connor AJ
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():63-9. PubMed ID: 25492173
[TBL] [Abstract][Full Text] [Related]
16. Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections.
Shunmugaperumal T; Kaur V; Thenrajan RS
Adv Exp Med Biol; 2015; 831():147-89. PubMed ID: 25384668
[No Abstract] [Full Text] [Related]
17. New horizons in antibacterial therapy.
Gritz DC; Hwang DG; Whitcher JP
Int Ophthalmol Clin; 1996; 36(2):153-70. PubMed ID: 8950639
[No Abstract] [Full Text] [Related]
18. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.
Xie S; Tao Y; Pan Y; Qu W; Cheng G; Huang L; Chen D; Wang X; Liu Z; Yuan Z
J Control Release; 2014 Aug; 187():101-17. PubMed ID: 24878179
[TBL] [Abstract][Full Text] [Related]
19. Charge-directed targeting of antimicrobial protein-nanoparticle conjugates.
Satishkumar R; Vertegel A
Biotechnol Bioeng; 2008 Jun; 100(3):403-12. PubMed ID: 18183633
[TBL] [Abstract][Full Text] [Related]
20. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
